A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias

Jorge E. Cortes, D. W. Kim, J. Pinilla-Ibarz, P. Le Coutre, R. Paquette, C. Chuah, F. E. Nicolini, J. F. Apperley, H. J. Khoury, M. Talpaz, J. DiPersio, D. J. DeAngelo, E. Abruzzese, D. Rea, M. Baccarani, M. C. Müller, C. Gambacorti-Passerini, S. Wong, S. Lustgarten, V. M. RiveraT. Clackson, C. D. Turner, F. G. Haluska, F. Guilhot, M. W. Deininger, A. Hochhaus, T. Hughes, J. M. Goldman, N. P. Shah, H. Kantarjian

Research output: Contribution to journal › Article › peer-review

895 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias'. Together they form a unique fingerprint.

Medicine & Life Sciences